Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Alam John J
Relationship:   CEO & President, Direc...
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   866,331    

Indirect Shares

  737,179      
Direct Value   $66,200,832    

Indirect Value

  $2,608,077      
Total Shares   1,603,510      
Total Value   $68,808,909      


Vertex Pharmaceuticals Inc
 $66,076,008 Cervomed Ord Shs
 $124,824 Vertex Pharmaceuticals Inc
 $66,076,008 Cervomed Ord Shs
 $124,824
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP, Med. Dev. Group &... 2008-10-01 136,792 2008-10-01 5,140    Premium*  
            Cervomed Ord Shs CRVO CEO & President, Direc... 2023-11-09 729,539 2023-11-09 732,039    Premium*  
* Premium Members only  

Records found :    68         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CRVO Cervomed Ord Shs CEO and PresidentOfficer   •       •       •   2023-08-16 3 IO $0.00 $0 I/I 0 742,039 -
CRVO Cervomed Ord Shs CEO and PresidentOfficer   •       •       •   2023-08-16 3 IO $0.00 $0 D/D 0 742,039 -
VRTX Vertex Pharmaceuticals In... EVP, Medicines Dev. & CMO   •       –      –    2007-11-16 4 AS $25.82 $26 D/D (1) 119,324 0 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2008-05-21 4 AS $27.89 $2,231 D/D (80) 128,511 0 -
VRTX Vertex Pharmaceuticals In... EVP, Medicines Dev. & CMO   •       –      –    2007-12-11 4 AS $25.41 $12,298 D/D (480) 118,844 0 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2008-05-20 4 AS $27.47 $19,918 D/D (722) 128,591 0 -
VRTX Vertex Pharmaceuticals In... EVP, Medicines Dev. & CMO   •       –      –    2007-05-17 4 AS $31.95 $25,368 D/D (794) 119,324 0 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2006-09-06 4 AS $35.59 $53,385 D/D (1,500) 103,856 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2006-09-06 4 OE $18.47 $27,705 D/D 1,500 195,356 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2006-10-18 4 OE $18.47 $27,705 D/D 1,500 105,356 0 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2006-10-18 4 AS $36.26 $54,390 D/D (1,500) 103,856 0 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2006-11-08 4 OE $18.47 $27,705 D/D 1,500 105,356 0 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2006-11-08 4 AS $41.49 $62,235 D/D (1,500) 103,856 0 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2006-11-15 4 OE $18.47 $27,705 D/D 1,500 106,063 0 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2006-11-22 4 AS $44.36 $66,540 D/D (1,500) 104,563 0 -
VRTX Vertex Pharmaceuticals In... EVP, Med. Dev. Group & CMO   •       –      –    2006-11-22 4 OE $18.47 $27,705 D/D 1,500 106,063 0 -
VRTX Vertex Pharmaceuticals In... EVP, Medicines Dev. & CMO   •       –      –    2006-11-29 4 AS $44.21 $66,315 D/D (1,500) 103,856 0 -
VRTX Vertex Pharmaceuticals In... EVP, Medicines Dev. & CMO   •       –      –    2006-11-29 4 OE $9.07 $23,005 D/D 1,500 105,356 0 -
VRTX Vertex Pharmaceuticals In... EVP, Medicines Dev. & CMO   •       –      –    2006-12-06 4 AS $44.69 $67,035 D/D (1,500) 103,856 0 -
VRTX Vertex Pharmaceuticals In... EVP, Medicines Dev. & CMO   •       –      –    2006-12-06 4 OE $9.07 $23,005 D/D 1,500 105,356 0 -
VRTX Vertex Pharmaceuticals In... EVP, Medicines Dev. & CMO   •       –      –    2006-12-13 4/A OE $9.07 $23,005 D/D 1,500 105,356 0 -
VRTX Vertex Pharmaceuticals In... SVP, Drug Eval. & Appr.   •       –      –    2006-12-20 4 OE $9.07 $23,005 D/D 1,500 104,876 0 -
VRTX Vertex Pharmaceuticals In... SVP, Drug Eval. & Appr.   •       –      –    2006-12-20 4 AS $37.78 $56,670 D/D (1,500) 103,376 0 -
VRTX Vertex Pharmaceuticals In... SVP, Drug Eval. & Appr.   •       –      –    2006-12-27 4 OE $9.07 $23,005 D/D 1,500 104,876 0 -
VRTX Vertex Pharmaceuticals In... SVP, Drug Eval. & Appr.   •       –      –    2006-12-27 4 AS $37.56 $56,340 D/D (1,500) 103,376 0 -

  68  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed